Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rong Xin

Showing results (281-290 of 339) with videos related to

Pageof 34
Sort By:
Cancer Science|July 13, 2017
Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatmentRui Zhang, Min Ma, Gang Dong, et al.
Neurobiology of Disease|January 10, 2025
Astrocytic NLRP3 cKO mitigates depression-like behaviors induced by mild TBI in miceHui-Tao Miao, Jun Wang, Jing-Jing Shao, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 22, 2008
Basic fibroblast growth factor (bFGF) alleviates the scar of the rabbit ear model in wound healingJu Lin Xie, Hui Ning Bian, Shao Hai Qi, et al.
Oncotarget|June 11, 2016
LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathwayShi-Peng Li, Hai-Xu Xu, Yao Yu, et al.
International Immunopharmacology|December 8, 2005
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomasXiu-wu Bian, Xue-feng Jiang, Jian-hong Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 4, 2018
Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing EzrinNi Sun, Chen-Yi Wang, Yi-Qun Sun, et al.
Clinical and Experimental Immunology|March 26, 2023
Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapyShu-Jung Hsu, Yen-Cheng Chao, Xia-Hui Lin, et al.
Medical Oncology (Northwood, London, England)|February 21, 2015
Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patientsLan Zhang, Ning-Lin Ge, Yi Chen, et al.
Plos One|March 12, 2014
Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinomaRong-Xin Chen, Hai-Yan Song, Yin-Ying Dong, et al.
Cell Death & Disease|May 6, 2022
Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapyWen-Juan Ma, Yukun Chen, Jian-Hong Peng, et al.
Pageof 34

Showing results (281-290 of 339) with videos related to

Sort By:
Pageof 34
Cancer Science|July 13, 2017
Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatmentRui Zhang, Min Ma, Gang Dong, et al.
Neurobiology of Disease|January 10, 2025
Astrocytic NLRP3 cKO mitigates depression-like behaviors induced by mild TBI in miceHui-Tao Miao, Jun Wang, Jing-Jing Shao, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 22, 2008
Basic fibroblast growth factor (bFGF) alleviates the scar of the rabbit ear model in wound healingJu Lin Xie, Hui Ning Bian, Shao Hai Qi, et al.
Oncotarget|June 11, 2016
LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathwayShi-Peng Li, Hai-Xu Xu, Yao Yu, et al.
International Immunopharmacology|December 8, 2005
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomasXiu-wu Bian, Xue-feng Jiang, Jian-hong Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 4, 2018
Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing EzrinNi Sun, Chen-Yi Wang, Yi-Qun Sun, et al.
Clinical and Experimental Immunology|March 26, 2023
Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapyShu-Jung Hsu, Yen-Cheng Chao, Xia-Hui Lin, et al.
Medical Oncology (Northwood, London, England)|February 21, 2015
Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patientsLan Zhang, Ning-Lin Ge, Yi Chen, et al.
Plos One|March 12, 2014
Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinomaRong-Xin Chen, Hai-Yan Song, Yin-Ying Dong, et al.
Cell Death & Disease|May 6, 2022
Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapyWen-Juan Ma, Yukun Chen, Jian-Hong Peng, et al.
Pageof 34